ALVR NASDAQ
AlloVir, Inc.
1W: +3.4%
1M: -0.9%
3M: -7.3%
1Y: -41.3%
3Y: -94.2%
$9.81
Last traded 2025-03-18 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
2 relationships0
As Filer
counterparties named
2
As Counterparty
mentioned by others
2023-05-01
Earliest Filing
2025-03-18
Latest Filing
Mentioned As Counterparty
2 mentionsOther companies that named ALVR in their SEC 8-K filings.
| Filed By | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|
| KLRS Kalaris Therapeutics, Inc. | target | Acquired Kalaris Therapeutics, Inc. in a merger transaction consummated on March 18, 2025. | 2025-03-18 | View |
| MRKR Marker Therapeutics, Inc. | partner | Received development services from Marker Therapeutics, Inc. under a services agreement. | 2023-05-01 | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR